Furthermore, activation of aSMase correlates with reported elevated levels of ceramide in the brain and cerebrospinal fluid of AD patients, which possibly is a result of increased expression of CERS1, CERS2, aSMase, nSMase and galactosylceramidase [142–146]. Here, SMPD1 is linked to Alzheimer disease.